A detailed history of Camden Capital, LLC transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, Camden Capital, LLC holds 711 shares of WST stock, worth $213,406. This represents 0.02% of its overall portfolio holdings.

Number of Shares
711
Previous 744 4.44%
Holding current value
$213,406
Previous $294,000 20.41%
% of portfolio
0.02%
Previous 0.03%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

SELL
$314.68 - $395.94 $10,384 - $13,066
-33 Reduced 4.44%
711 $234,000
Q1 2024

May 15, 2024

BUY
$338.27 - $413.0 $1,353 - $1,652
4 Added 0.54%
744 $294,000
Q4 2023

Feb 05, 2024

BUY
$318.29 - $392.21 $235,534 - $290,235
740 New
740 $260,000
Q4 2021

Feb 14, 2022

BUY
$402.25 - $471.34 $177,392 - $207,860
441 New
441 $207,000
Q3 2021

Nov 03, 2021

SELL
$363.01 - $468.47 $202,559 - $261,406
-558 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$284.77 - $363.2 $158,901 - $202,665
558 New
558 $200,000

Others Institutions Holding WST

About WEST PHARMACEUTICAL SERVICES INC


  • Ticker WST
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 74,033,000
  • Market Cap $22.2B
  • Description
  • West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...
More about WST
Track This Portfolio

Track Camden Capital, LLC Portfolio

Follow Camden Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Camden Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Camden Capital, LLC with notifications on news.